MedPath

江西生物制品研究所股份有限公司

Ownership
-
Established
1985-04-01
Employees
-
Market Cap
-
Website
www.jxswzp.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Tetanus Antitoxin

Product Name
破伤风抗毒素
Approval Number
国药准字S20258003
Approval Date
Mar 13, 2025
NMPA

Tetanus Antitoxin

Product Name
破伤风抗毒素
Approval Number
国药准字S20247010
Approval Date
Feb 24, 2025
NMPA

Tetanus Antitoxin

Product Name
破伤风抗毒素
Approval Number
国药准字S10970021
Approval Date
Oct 27, 2020
NMPA

Tetanus Antitoxin

Product Name
破伤风抗毒素
Approval Number
国药准字S10970022
Approval Date
Oct 27, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.